GAIN THERAPEUTICS INC

Ticker: GANX CUSIP: 36269B105 Class: COM

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 35,820 Value ($000) $115 Avg Close $2.67 Range $1.66 - $4.34
Q3 2025
Shares 35,820 Value ($000) $63 Avg Close $1.69 Range $1.41 - $2.12
Q2 2025
Shares 35,820 Value ($000) $64 Avg Close $1.85 Range $1.48 - $2.27
Q1 2025
Shares 35,820 Value ($000) $68 Avg Close $2.22 Range $1.54 - $2.81
Q4 2024
Shares 35,820 Value ($000) $77 Avg Close $2.01 Range $1.50 - $3.19
Q3 2024
Shares 35,820 Value ($000) $64 Avg Close $1.26 Range $0.89 - $2.00
Q2 2024
Shares 35,820 Value ($000) $46 Avg Close $2.60 Range $1.20 - $4.04
Q1 2024
Shares 35,820 Value ($000) $135 Avg Close $4.15 Range $3.17 - $5.33
Q4 2023
Shares 58,100 Value ($000) $190 Avg Close $2.78 Range $2.00 - $3.49
Q3 2023
Shares 58,100 Value ($000) $191 Avg Close $3.79 Range $3.03 - $4.78
Q2 2023
Shares 58,100 Value ($000) $260 Avg Close $4.88 Range $4.25 - $6.19
Q1 2023
Shares 58,100 Value ($000) $280 Avg Close $4.09 Range $3.15 - $5.25
Q4 2022
Shares 58,100 Value ($000) $182 Avg Close $3.13 Range $2.80 - $3.46
Q3 2022
Shares 58,100 Value ($000) $189 Avg Close $3.76 Range $3.12 - $4.28
Q2 2022
Shares 58,100 Value ($000) $209 Avg Close $3.45 Range $2.33 - $6.70
Q1 2022
Shares 58,100 Value ($000) $238 Avg Close $4.18 Range $2.98 - $6.05
Q4 2021
Shares 58,100 Value ($000) $315 Avg Close $6.90 Range $5.25 - $9.70
Q3 2021
Shares 58,100 Value ($000) $433 Avg Close $8.36 Range $6.90 - $10.48
Q2 2021
Shares 58,100 Value ($000) $581 Avg Close $11.28 Range $8.71 - $17.93
Q1 2021
Shares 58,100 Value ($000) $867 Avg Close $13.34 Range $11.30 - $15.45